[HTML][HTML] Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis
D Li, EK Schneider-Futschik - Antibiotics, 2023 - mdpi.com
Characterized by impaired mucus transport and subsequent enhanced colonization of
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
bacteria, pulmonary infection causes major morbidity and mortality in patients with cystic …
New developments in inhaled antibiotics for the treatment of Pseudomonas aeruginosa
T Hofmann - Current pharmaceutical design, 2012 - ingentaconnect.com
The field of inhaled antibiotics that target Pseudomonas aeruginosa infections has made
substantial contributions to the health, disease management, and life expectancies of …
substantial contributions to the health, disease management, and life expectancies of …
[HTML][HTML] Comparison of inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa lung infection in patients with cystic fibrosis: systematic literature …
Abstract Purpose In Europe, 4 inhaled antibiotics (tobramycin, colistimethate sodium,
aztreonam, and levofloxacin) are currently approved for the treatment of chronic …
aztreonam, and levofloxacin) are currently approved for the treatment of chronic …
[HTML][HTML] Cystic fibrosis: recent insights into inhaled antibiotic treatment and future perspectives
G Taccetti, M Francalanci, G Pizzamiglio, B Messore… - Antibiotics, 2021 - mdpi.com
Although new inhaled antibiotics have profoundly improved respiratory diseases in cystic
fibrosis (CF) patients, lung infections are still the leading cause of death. Inhaled antibiotics …
fibrosis (CF) patients, lung infections are still the leading cause of death. Inhaled antibiotics …
Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics
M Ballmann, A Smyth, DE Geller - Respiratory medicine, 2011 - Elsevier
Chronic airway infection and inflammation are key events in the clinical course of cystic
fibrosis (CF). The most relevant, best investigated strain of bacteria in these circumstances is …
fibrosis (CF). The most relevant, best investigated strain of bacteria in these circumstances is …
Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis
S Antoniu - Expert Review of Anti-infective Therapy, 2015 - Taylor & Francis
In cystic fibrosis, chronic airways infection caused by Pseudomonas aeruginosa can be
treated with inhaled antibiotics such as inhaled tobramycin, aztreonam or colistin. However …
treated with inhaled antibiotics such as inhaled tobramycin, aztreonam or colistin. However …
Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled …
L Máiz, RM Girón, C Olveira, E Quintana… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Inhaled antibiotics are probably the safest and most effective therapy for
Pseudomonas aeruginosa chronic lung infection in cystic fibrosis (CF) patients. Areas …
Pseudomonas aeruginosa chronic lung infection in cystic fibrosis (CF) patients. Areas …
Inhaled antibiotics: the new era of personalized medicine?
JA Biller - Current Opinion in Pulmonary Medicine, 2015 - journals.lww.com
Inhaled antibiotics remain an important treatment option in cystic fibrosis due to chronic
airway infection as a hallmark of the disease. Although there are now multiple options for …
airway infection as a hallmark of the disease. Although there are now multiple options for …
Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis
Abstract Background: Pseudomonas aeruginosa (Pa) is the predominant pathogen infecting
the airways of patients with cystic fibrosis (CF). Initial colonization is usually transient and …
the airways of patients with cystic fibrosis (CF). Initial colonization is usually transient and …
[HTML][HTML] A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis
KJ Littlewood, K Higashi, JP Jansen… - Journal of Cystic …, 2012 - Elsevier
BACKGROUND: Various inhaled antibiotics are currently used for treating chronic
Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients, however their …
Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients, however their …
相关搜索
- inhaled antibiotics cystic fibrosis
- inhaled antibiotics meta analysis
- meta analysis cystic fibrosis
- inhaled antibiotics pseudomonas infections
- pseudomonas infections cystic fibrosis
- inhaled antibiotics personalized medicine
- meta analysis pseudomonas infections
- inhaled antibiotics pseudomonas aeruginosa
- pseudomonas aeruginosa cystic fibrosis
- respiratory infections cystic fibrosis